title: Fulminant liver failure during interferon beta treatment of multiple sclerosis.
authors.affiliation: Department of Medicine, the University of British Columbia and the British Columbia Transplant Society, Vancouver, Canada.
authors.forename: E M
authors.initials: EM
authors.lastname: Yoshida
authors.forename: S L
authors.initials: SL
authors.lastname: Rasmussen
authors.forename: U P
authors.initials: UP
authors.lastname: Steinbrecher
authors.forename: S R
authors.initials: SR
authors.lastname: Erb
authors.forename: C H
authors.initials: CH
authors.lastname: Scudamore
authors.forename: S W
authors.initials: SW
authors.lastname: Chung
authors.forename: J J
authors.initials: JJ
authors.lastname: Oger
authors.forename: S A
authors.initials: SA
authors.lastname: Hashimoto
mesh_terms: D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D017093:Liver Failure / Q000139:chemically induced* / Q000503:physiopathology / Q000601:surgery; D016031:Liver Transplantation; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D016899:Interferon-beta